OmniVis
PrivateLast Round
Accelerator
Feb 1, 2023
Total Funding Raised
$1.47M
Company Overview
OmniVis operates in Healthcare & Life Sciences and is based in South San Francisco, California. Its latest recorded funding round was an Accelerator round in February 2023.
OmniVis is a biotechnology company that develops rapid, smartphone-enabled diagnostic devices for detecting pathogens in water, food, and clinical samples.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Biotech Equipment, Environmental Monitoring
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OmniVis Comparables
Compare OmniVis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biomeme | 84% | |
| ProtonDx | 81% | |
| Kraken Sense | 78% |
For institutional investors. Book with your work email.
OmniVis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Feb 1, 2023 | ||||
| Seed | Mar 15, 2022 | ||||
| Grant | Jul 1, 2020 | ||||
| Grant | Apr 15, 2020 | ||||
| Grant | Jul 1, 2018 |
For institutional investors. Book with your work email.
OmniVis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Indiana Economic Development Corporation | Grant |
| Purdue Ag-Celerator | Accelerator |
| Halcyon Venture Partners | Seed |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2023
$100K round from Purdue Ag-Celerator
- Mar 15, 2022
$100K round led by Halcyon Venture Partners
For institutional investors. Book with your work email.
OmniVis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OmniVis's valuation, stock price, and market status.
Is OmniVis a public or private company?
OmniVis is a private company.
What is the current stock price of OmniVis?
OmniVis is a private company, so its shares have no public market price. Caplight tracks OmniVis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OmniVis worth (valuation)?
Valuation information for OmniVis is not publicly available.
Can I buy OmniVis stock?
OmniVis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OmniVis's last funding round?
OmniVis's most recent funding round was Accelerator on February 1, 2023.
Who are the main investors in OmniVis?
Key investors in OmniVis include Indiana Economic Development Corporation, Purdue Ag-Celerator, Halcyon Venture Partners, National Science Foundation.
Will OmniVis IPO soon?
No public IPO plans have been announced for OmniVis.
How can I track OmniVis secondary market activity?
Caplight tracks bids, offers, and trades in OmniVis's shares on secondary markets.